Learn More
AIMS The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant cytotoxic chemotherapy to survival in adult cancer patients. MATERIALS AND METHODS We undertook a literature search for randomised clinical trials reporting a 5-year survival benefit attributable solely to cytotoxic(More)
  • 1